SCHEMBL24915325

SCHEMBL24915325

CCOC(=O)c1ccn(C2CCOC2)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNF P01375 1/20 0.40
CYP1A2 P05177 1/20 0.39
FAAH O00519 4/20 0.39
PDE4B Q07343 2/20 0.37
ACKR3 P25106 1/20 0.37
KDM4E B2RXH2 3/20 0.36
POLB P06746 1/20 0.36
PIK3CA P42336 1/20 0.36
SRC P12931 1/20 0.36
MGLL Q99685 1/20 0.36
OGFRL1 Q5TC84 1/20 0.36
ALDH1A1 P00352 1/20 0.35
TP53 P04637 1/20 0.35
HPGD P15428 1/20 0.35
HSD17B10 Q99714 1/20 0.35
JMJD6 Q6NYC1 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
CASP3 P42574 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15754077 0.92 ACKR3 (0.42) CYP1A2FAAHPDE4BACKR3KDM4E
SCHEMBL24915580 0.90 CYP1A2 (0.43) CYP1A2FAAHKDM4EPOLBPIK3CA
SCHEMBL16244534 0.85 CYP1A2 (0.46) CYP1A2FAAHKDM4EPOLBALDH1A1
SCHEMBL22637340 0.83 CYP1A2 (0.44) CYP1A2FAAHKDM4EPOLBOGFRL1
SCHEMBL31389468 0.82 ALDH1A1 (0.46) CYP1A2FAAHPOLBOGFRL1ALDH1A1
SCHEMBL20046891 0.81 CYP1A2 (0.42) CYP1A2FAAHKDM4EPOLBJMJD6
SCHEMBL20046898 0.80 CYP1A2 (0.41) CYP1A2FAAHKDM4EPOLBALDH1A1
SCHEMBL14636109 0.80 PLAT (0.42) CYP1A2FAAHKDM4EPOLB
SCHEMBL20722095 0.79 CYP1A2 (0.43) CYP1A2FAAHKDM4EPOLBALDH1A1
SCHEMBL20722078 0.79 CYP1A2 (0.43) CYP1A2FAAHKDM4EPOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230145793-A1 SUBSTITUTED PYRIMIDINE OR PYRIDINE AMINE DERIVATIVE, COMPOSITION THEREOF, AND MEDICAL USE THEREOF SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) 2023-05-11 US disclosed
US-20230145793-A1 SUBSTITUTED PYRIMIDINE OR PYRIDINE AMINE DERIVATIVE, COMPOSITION THEREOF, AND MEDICAL USE THEREOF SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) 2023-05-11 US disclosed
EP-4122927-A1 SUBSTITUTED PYRIMIDINE OR PYRIDINE AMINE DERIVATIVE, COMPOSITION THEREOF, AND MEDICAL USE THEREOF Shanghai Haiyan Pharmaceutical Technology Co., Ltd. (CN) 2023-01-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230145793-A1 SUBSTITUTED PYRIMIDINE OR PYRIDINE AMINE DERIVATIVE, COMPOSITION THEREOF, AND MEDICAL USE THEREOF ADORA2A, ADORA2B, ADORA3 TNF 4703/4885CYP1A2 170/4885FAAH 1125/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.